CONSENSUS STATEMENT FOR DECREASING THE RISK OF TORSADES DE POINTES IN PATIENTS ON QT-PROLONGING COVID-19 ANTI-VIRAL DRUGS (Chloroquine, Hydroxychloroquine, Azithromycin, Lopinavir/Ritonavir)

CONSENSUS STATEMENT FOR DECREASING THE RISK OF TORSADES DE POINTES IN PATIENTS ON QT PROLONGING COVID 19 ANTI VIRAL DRUGS 1 1

CONSENSUS STATEMENT FOR DECREASING THE RISK OF TORSADES DE POINTES IN PATIENTS ON QT PROLONGING COVID 19 ANTI VIRAL DRUGS 1 2